Growth Metrics

BioNTech SE (BNTX) Non-Current Deferred Tax Liability (2020 - 2025)

BioNTech SE's Non-Current Deferred Tax Liability history spans 6 years, with the latest figure at $98.1 million for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 116.58% to $98.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $98.1 million, a 116.58% increase, with the full-year FY2025 number at $95.2 million, up 110.21% from a year prior.
  • Non-Current Deferred Tax Liability hit $98.1 million in Q4 2025 for BioNTech SE, up from $28.3 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for BNTX hit a ceiling of $107.1 million in Q2 2022 and a floor of $4.9 million in Q2 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $42.9 million across 5 years, with a median of $42.7 million in 2023.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 31898.45% in 2021 and later tumbled 95.43% in 2023.
  • Tracing BNTX's Non-Current Deferred Tax Liability over 5 years: stood at $76.3 million in 2021, then crashed by 91.71% to $6.3 million in 2022, then surged by 575.28% to $42.7 million in 2023, then grew by 6.07% to $45.3 million in 2024, then soared by 116.58% to $98.1 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for BNTX at $98.1 million in Q4 2025, $28.3 million in Q3 2025, and $32.3 million in Q2 2025.